OPPENHEIMER HOLDINGS INC (OPY) earnings date, results and what the price requires
NYSE · SEC CIK 0000791963 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $389.4M | $27.4M | $2.38 | Filing |
| Mar 31, 2026 | May 1, 2026 | $399.4M | $-20.6M | $-1.93 | Filing |
| Dec 31, 2025 | Jan 30, 2026 | $416.3M | $74.4M | $6.51 | Filing |
| Sep 30, 2025 | Oct 31, 2025 | $370.2M | $21.7M | $1.90 | Filing |
| Jun 30, 2025 | Aug 1, 2025 | $313.4M | $21.7M | $1.91 | Filing |
| Mar 31, 2025 | Apr 25, 2025 | $324.1M | $30.7M | $2.72 | Filing |
| Dec 31, 2024 | Jan 31, 2025 | $325.9M | $10.7M | $0.92 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $316.6M | $24.5M | $2.16 | Filing |
What would OPPENHEIMER HOLDINGS INC have to report for its valuation to change?
At $102.14, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -0.3% a year, to $8.73. On that path the next quarter needs diluted EPS near $1.89, against $1.90 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -0.3% | -0.3% |
| EPS needed in final year | $8.73 | $8.73 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. OPY goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.